Market Access Communications

In an independent survey, 82% of surveyed clients said that Evidera was distinct from the competition in its experience communicating value to payers.

Services & Products

  • Webinars

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides
    See More
  • White Papers

    Whitepaper

    Navigating the Maze - Market Access for Medical Devices: Planning Beyond Regulatory Approval

    Authors: Durgesh Kahol, MBA, (Former) Senior Business Analyst, Payer Strategy, Evidera; Laura Haycock, MBioEnt, Senior Market Access Writer, Payer Communications, Evidera; Helena Emich, PhD, Market Access Writer, Payer Communications, Evidera

    Year: 2015

    View

    Whitepaper

    What's in a Name? Systematic and Non-Systematic Literature Reviews, and Why the Distinction Matters

    Authors: Rachel Huelin, Director and Research Scientist, Meta Research; Ike Iheanacho, MBBS, Director and Research Scientist, Meta Research; Krista Payne, MEd, Executive Director, Evidence Strategy Solutions; Karen Sandman, PhD, U.S. Practice Lead, Payer Communications

    Year: 2015

    View

    Whitepaper

    The Evidence Requirements for Orphan Drugs from a Payer Perspective

    Authors: Karen Sandman, PhD, U.S. Practice Lead, Payer Communications, Evidera

    Year: 2014

    View
    See More
  • Fact Sheets

    Fact Sheet

    Market Access Communication Services
    Download

    Fact Sheet

    Transform Communication of Product Value with iValue Suite™
    Download

    Fact Sheet

    Medical Writing and Healthcare Communications
    Download

    Fact Sheet

    Conveying Product Value with the AMCP Format Version 4.0
    Download

A dense compendium of evidence is not enough to communicate product value to payers. Summarizing the best available evidence is important, but the dossier should also tell a story — accurately, succinctly and engagingly — about the value of your product. Our dedicated in-house team of specialist market access writers reviews the clinical, economic and humanistic evidence to develop compelling value stories, dossiers, payer communication decks and objection handlers.

Our value messages are often tested and validated with payers in key markets, and we are well-versed in the templates and formats for country-specific dossiers, including those for the U.S. (AMCP/WellPoint), Canada, the U.K. and various other European markets. For a successful journey through client review processes, we apply rigorous quality standards to all content development, with attention to primary referencing and appropriate interpretation of data drawn from the published literature.

Offerings

Global Value Dossiers and Associated Support

Present payer-relevant evidence to ensure optimal market access; supplemented by slide decks, objection handlers and training activities as needed.

Value Story Development

Articulate a logical flow of arguments, supported by the best available data, developed and refined iteratively through the product life cycle.

Country-Specific Submissions

Support communication of product value via single country pricing and reimbursement or formulary submissions.

Academy of Managed Care Pharmacy (AMCP) Dossiers

Tailor your market access deliverables to the U.S. managed care payer audience.

Payer Landscape and Disease Area Strategy Reviews

Explore detailed baseline information on the payer environment, conducted early in development.

iValue Suite®

Present messages and evidence in a dynamic and user-friendly way via a web-based tool or mobile application for iPad. Click here for more info.

Market Access Communications Experts

Services & Products

  • Webinars

    Webinar

    Adaptive Pathways and HTAs: Trade-offs in Implementation between Speed and Uncertainty

    Presenters: Susanne Michel, MD, European Practice Leader, Payer Strategy; Yvonne Beatrice Boehler, MD, MBA, Prof. TH Koln University; Agnes Benedict, MA, MSc, Sr. Research Scientist, M&S and Exec. Dir. Center of Excellence - HE; Noemi Muszbek, MA, MSc, Sr. Research Scientist, M&S

    Additional Info
    Contact us for slides
    See More
  • White Papers

    Whitepaper

    Navigating the Maze - Market Access for Medical Devices: Planning Beyond Regulatory Approval

    Authors: Durgesh Kahol, MBA, (Former) Senior Business Analyst, Payer Strategy, Evidera; Laura Haycock, MBioEnt, Senior Market Access Writer, Payer Communications, Evidera; Helena Emich, PhD, Market Access Writer, Payer Communications, Evidera

    Year: 2015

    View

    Whitepaper

    What's in a Name? Systematic and Non-Systematic Literature Reviews, and Why the Distinction Matters

    Authors: Rachel Huelin, Director and Research Scientist, Meta Research; Ike Iheanacho, MBBS, Director and Research Scientist, Meta Research; Krista Payne, MEd, Executive Director, Evidence Strategy Solutions; Karen Sandman, PhD, U.S. Practice Lead, Payer Communications

    Year: 2015

    View

    Whitepaper

    The Evidence Requirements for Orphan Drugs from a Payer Perspective

    Authors: Karen Sandman, PhD, U.S. Practice Lead, Payer Communications, Evidera

    Year: 2014

    View
    See More
  • Fact Sheets

    Fact Sheet

    Market Access Communication Services
    Download

    Fact Sheet

    Transform Communication of Product Value with iValue Suite™
    Download

    Fact Sheet

    Medical Writing and Healthcare Communications
    Download

    Fact Sheet

    Conveying Product Value with the AMCP Format Version 4.0
    Download
Back to Top